Eli Lilly's weight loss pill succeeds in first late-stage trial on diabetes patients

Source: CNBC | Published: April 17, 2025, 11:53 a.m.

The results bring Eli Lilly's pill orforglipron one step closer to becoming a new, needle-free alternative in the booming weight loss and diabetes market.

Read Original Article Back to News List

Related News

Read Hertz CEO's letter to employees about Bill Ackman's 'significant' stake in the rental car firm

8 hours, 47 minutes ago

Trump renews call for interest rate cut, says rates would be lower if Fed chief Powell 'understood what he was doing'

12 hours, 27 minutes ago

Capital One and Discover merger approved by Federal Reserve

13 hours, 13 minutes ago

Nintendo Switch 2 retail preorder to begin April 24 following tariff delays

15 hours, 7 minutes ago

U.S. proposes lighter sanctions on Russia as part of peace plan with Ukraine: Bloomberg

15 hours, 59 minutes ago